Hideo Tsukada Selected Research

TRA418

11/2005

PET study of the neuroprotective effect of TRA-418, an antiplatelet agent, in a monkey model of stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hideo Tsukada Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 01/2002
9	Ischemia 01/2020 - 01/2002
8	Parkinson Disease (Parkinson's Disease) 10/2022 - 05/2005
7	Brain Ischemia (Cerebral Ischemia) 04/2017 - 01/2002
7	Infarction (Infarctions) 01/2017 - 11/2006
6	Cognitive Dysfunction 01/2022 - 06/2011
6	Neuroinflammatory Diseases 01/2021 - 04/2014
6	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2016 - 01/2002
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 07/2018
5	Alzheimer Disease (Alzheimer's Disease) 10/2020 - 09/2008
5	Stroke (Strokes) 01/2017 - 01/2002
4	Dementia (Dementias) 10/2022 - 02/2009
4	Cerebral Infarction 01/2016 - 05/2007
4	Ischemic Stroke 01/2016 - 02/2009
4	Schizophrenia (Dementia Praecox) 02/2010 - 08/2004
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 05/2004
3	Thrombosis (Thrombus) 10/2012 - 05/2007
3	Neoplasm Metastasis (Metastasis) 01/2012 - 01/2002
3	Overactive Urinary Bladder (Overactive Bladder) 09/2011 - 06/2008
2	Atrophy 10/2022 - 01/2022
2	Brain Injuries (Brain Injury) 10/2021 - 08/2003
2	Brain Neoplasms (Brain Tumor) 06/2018 - 01/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 02/2009
2	Melanoma (Melanoma, Malignant) 01/2013 - 05/2008
2	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 01/2012 - 12/2004
2	Pain (Aches) 12/2007 - 01/2006
1	Lewy Body Disease (Lewy Body Dementia) 10/2022
1	Hypersensitivity (Allergy) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Brain Diseases (Brain Disorder) 12/2021
1	Tauopathies 10/2020
1	Kidney Diseases (Kidney Disease) 01/2020
1	Glomerulonephritis 01/2020
1	Fibrosis (Cirrhosis) 07/2018
1	Asthma (Bronchial Asthma) 01/2018
1	Rheumatoid Arthritis 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2018
1	Epilepsy (Aura) 01/2018

Drug/Important Bio-Agent (IBA)

8	Liposomes (Liposome)IBA 08/2014 - 04/2002
7	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 01/2003
6	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 01/2023 - 01/2016
6	LigandsIBA 01/2020 - 01/2002
6	Oxygen (Dioxygen)IBA 04/2017 - 11/2006
5	Amyloid (Amyloid Fibrils)IBA 01/2022 - 10/2013
5	Proteins (Proteins, Gene)FDA Link 10/2020 - 05/2005
5	2- tert- butyl- 4- chloro- 5- (6- (2- (2- fluoroethoxy)ethoxy)pyridin- 3- ylmethoxy)- 2H- pyridazin- 3- oneIBA 10/2020 - 01/2014
5	Tyrosine (L-Tyrosine)FDA Link 06/2018 - 04/2005
5	liposome-encapsulated hemoglobinIBA 04/2017 - 05/2007
5	Dopamine (Intropin)FDA LinkGeneric 01/2016 - 08/2004
5	Cholinergic Agents (Cholinergics)IBA 10/2013 - 01/2002
5	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 10/2013 - 05/2004
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2017 - 06/2004
4	Neuroprotective AgentsIBA 01/2016 - 01/2002
4	triphenyltetrazoliumIBA 10/2012 - 05/2007
4	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 08/2011 - 06/2008
3	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2017 - 10/2012
3	Peptides (Polypeptides)IBA 01/2013 - 04/2002
3	Cholinergic ReceptorsIBA 01/2012 - 01/2002
3	N-methyl-3-piperidyl benzilateIBA 01/2012 - 01/2002
3	Muscarinic AntagonistsIBA 09/2011 - 06/2008
3	alanyl-prolyl-arginyl-prolyl-glycineIBA 01/2011 - 04/2002
3	Hemoglobins (Hemoglobin)IBA 02/2010 - 05/2007
3	Amino Acids FDA Link 04/2009 - 04/2005
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2022 - 12/2021
2	Adenosine Triphosphate (ATP)IBA 12/2021 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 01/2020
2	2- tert- butyl- 4- chloro- 5- (6- (4- fluorobutoxy)pyridin- 3- ylmethoxy)- 2H- pyridazin- 3- oneIBA 01/2020 - 07/2018
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 11/2019 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013 - 01/2012
2	CholesterolIBA 01/2013 - 08/2010
2	arginyl-glycyl-aspartic acidIBA 01/2013 - 01/2012
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2013 - 01/2011
2	GABA-A Receptors (GABA(A) Receptor)IBA 10/2012 - 01/2002
2	oxybutynin (Tavor)FDA LinkGeneric 09/2011 - 08/2011
2	VaccinesIBA 11/2010 - 07/2010
2	EnzymesIBA 08/2010 - 05/2005
2	Neurotransmitter Agents (Neurotransmitter)IBA 02/2009 - 12/2004
2	alovudineIBA 02/2009 - 10/2004
2	N-Methylaspartate (NMDA)IBA 09/2008 - 08/2004
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2008 - 08/2004
2	Analgesics (Analgesic Drugs)IBA 12/2007 - 01/2006
2	Epoprostenol ReceptorsIBA 11/2006 - 01/2002
2	Serotonin (5 Hydroxytryptamine)IBA 12/2004 - 08/2004
2	Matrix Metalloproteinases (MMPs)IBA 06/2004 - 01/2004
1	Pyruvic Acid (Pyruvate)IBA 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	SynucleinsIBA 10/2022
1	cremophor ELIBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2021
1	Quinolinic AcidIBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2018
1	Monoclonal AntibodiesIBA 01/2018

Therapy/Procedure

6	Therapeutics 01/2013 - 04/2002
3	Radiotherapy 01/2017 - 10/2004
2	Anesthesia 01/2006 - 01/2002
1	Nephrectomy 01/2020